New proposed monographs for dietary supplements

NewsGuard 100/100 Score

The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment.

Six Turmeric-related monographs and three Soy Isoflavones monographs appeared in Pharmacopeial Forum (PF) 33, the issue corresponding to November/December 2007. These are Turmeric, Powdered Turmeric, Powdered Turmeric Extract, Curcuminoids, Curcuminoids Capsules, Curcuminoids Tablets, Soy Isoflavones Extract, Soy Isoflavones Capsules, and Soy Isoflavones Tablets. Two monographs for single ingredient amino acid formulations, arginine capsules and arginine tablets also appeared in PF 33. PF is the journal through which USP offers, for public review and comments, new and revised standards pertaining to the United States Pharmacopeia–National Formulary.

“USP is pleased to release these new monographs in addition to the proposed monographs on Powdered Decaffeinated Green Tea Extract and Powdered Bilberry Extract published recently in PF 33 in July 2007,” said Darrell Abernethy, M.D., Ph.D., chief science officer at USP. “This is an important step towards advancing the quality of these dietary supplements, which are increasingly used by consumers. USP welcomes comments on the new monographs from all interested parties.”

The proposed monographs contain specific and validated analytical methods that will ensure the identity of the articles and protect consumers and industry from low quality and adulterated products. For example, the proposed monograph on Powdered Bilberry Extract distinguishes the true extract from articles adulterated with azo dyes and other anthocyanin-containing botanicals. Green Tea, Turmeric and Soy Isoflavones monographs were also the subjects of a number of the 2006 National Institutes of Health research grants.

All 11 monographs address articles that are of great interest to the dietary supplements industry and to the scientific community.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ADHD medication proves most effective in treating symptoms, new study finds